Clinical Trials

Showing trials with last updates posted in 2024.

NCT01897571 | COMPLETED | PHASE1/PHASE2
400 participants

Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-26
Start Date:
2013-06-13
Completion:
2021-08-24
Conditions
  • B-cell Lymphomas (Phase 1)
  • Advanced Solid Tumors (Phase 1)
  • Diffuse Large B-cell Lymphoma (Phase 2)
  • Follicular Lymphoma (Phase 2)
  • Transformed Follicular Lymphoma
  • Primary Mediastinal Large B-Cell Lymphoma
Interventions
  • DRUG
NCT01684150 | COMPLETED | PHASE1
51 participants

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-26
Start Date:
2012-09-30
Completion:
2015-11-30
Conditions
  • Acute Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Myelodysplastic Syndrome
  • Myeloproliferative Disorders
Interventions
  • DRUG
No Results Yet
NCT00381680 | COMPLETED | PHASE3
275 participants

Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2024-03-26
Start Date:
2007-03-31
Completion:
2016-03-31
Conditions
  • B-cell Childhood Acute Lymphoblastic Leukemia
  • L1 Childhood Acute Lymphoblastic Leukemia
  • L2 Childhood Acute Lymphoblastic Leukemia
  • Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia
Interventions
  • DRUG
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page